America September 3, 2024
Semnur Pharmaceuticals $2.5B Merger to Go Public via SPAC Deal
Semnur Pharmaceuticals Inc., advised by Paul Hastings LLP, unveiled plans on Tuesday to go public through a merger with Denali…
America September 3, 2024
Semnur Pharmaceuticals Inc., advised by Paul Hastings LLP, unveiled plans on Tuesday to go public through a merger with Denali…
By Rihem Akkouche